{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T19:24:29Z","timestamp":1740165869258,"version":"3.37.3"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,2,17]],"date-time":"2021-02-17T00:00:00Z","timestamp":1613520000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,2,17]],"date-time":"2021-02-17T00:00:00Z","timestamp":1613520000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CEN Case Rep"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s13730-021-00580-3","type":"journal-article","created":{"date-parts":[[2021,2,19]],"date-time":"2021-02-19T04:33:04Z","timestamp":1613709184000},"page":"414-421","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["An elderly-onset neuroblastoma concomitant with minimal change nephrotic syndrome: the first autopsy case report"],"prefix":"10.1007","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7871-2425","authenticated-orcid":false,"given":"Aya","family":"Nawata","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Izumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kohsuke","family":"Harada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Kurisu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shohei","family":"Shimajiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasumasa","family":"Matsuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiyuki","family":"Nakayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,2,17]]},"reference":[{"key":"580_CR1","doi-asserted-by":"publisher","first-page":"67","DOI":"10.4137\/CCRep.S16312","volume":"7","author":"T Akimoto","year":"2014","unstructured":"Akimoto T, Otani N, Takeshima E, Saito O, Kusano E, Nagata D. Do we have to perform a renal biopsy? Clinical dilemmas in a case with nephrotic syndrome. Clin Med Insights Case Rep. 2014;7:67\u201370.","journal-title":"Clin Med Insights Case Rep"},{"key":"580_CR2","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.critrevonc.2008.08.003","volume":"70","author":"J Bacchetta","year":"2009","unstructured":"Bacchetta J, Juillard L, Cochat P, Droz JP. Paraneoplastic glomerular diseases and malignancies. Crit Rev Oncol Hematol. 2009;70:39\u201358.","journal-title":"Crit Rev Oncol Hematol"},{"key":"580_CR3","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/nrneph.2010.171","volume":"7","author":"YH Lien","year":"2011","unstructured":"Lien YH, Lai LW. Pathogenesis, diagnosis and management of paraneoplastic glomerulonephritis. Nat Rev Nephrol. 2011;7:85\u201395.","journal-title":"Nat Rev Nephrol"},{"key":"580_CR4","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s00281-007-0094-z","volume":"29","author":"PW Mathieson","year":"2007","unstructured":"Mathieson PW. Minimal change nephropathy and focal segmental glomerulosclerosis. Semin Immunopathol. 2007;29:415\u201326.","journal-title":"Semin Immunopathol"},{"key":"580_CR5","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.2215\/CJN.03770412","volume":"7","author":"JF Cambier","year":"2012","unstructured":"Cambier JF, Ronco P. Onco-nephrology: glomerular diseases with cancer. Clin J Am Soc Nephrol. 2012;7:1701\u201312.","journal-title":"Clin J Am Soc Nephrol"},{"key":"580_CR6","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1002\/ijc.31399","volume":"143","author":"M Suzuki","year":"2018","unstructured":"Suzuki M, Kushner BH, Kramer K, Basu EM, Roberts SS, Hammond WJ, LaQuaglia MP, Wolden SL, Cheung NV, Modak S. Treatment and outcome of adult-onset neuroblastoma. Int J Cancer. 2018;143:1249\u201358.","journal-title":"Int J Cancer"},{"key":"580_CR7","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1056\/NEJMra0804577","volume":"362","author":"JM Maris","year":"2010","unstructured":"Maris JM. Recent advances in neuroblastoma. N Engl J Med. 2010;362:2202\u201311.","journal-title":"N Engl J Med"},{"key":"580_CR8","doi-asserted-by":"publisher","first-page":"6459","DOI":"10.1200\/JCO.2005.05.571","volume":"23","author":"WB London","year":"2005","unstructured":"London WB, Castleberry RP, Matthay KK, Look AT, Seeger RC, Shimada H, Thorner P, Brodeur G, Maris JM, Reynolds CP, Cohn SL. Evidence for an age cutoff greater than 365 days for neuroblastoma risk group stratification in the children\u2019s oncology group. J Clin Oncol. 2005;23:6459\u201365.","journal-title":"J Clin Oncol"},{"key":"580_CR9","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1016\/S0140-6736(07)60983-0","volume":"23","author":"JM Maris","year":"2007","unstructured":"Maris JM, Hogarty MD, Bagatell R, Cohn SL. Neuroblastoma. Lancet. 2007;23:2106\u201320.","journal-title":"Lancet"},{"key":"580_CR10","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1002\/(SICI)1097-0142(19990715)86:2<364::AID-CNCR21>3.0.CO;2-7","volume":"86","author":"H Shimada","year":"1999","unstructured":"Shimada H, Ambros IM, Dehner LP, et al. The international neuroblas toma pathology classification (the Shimada system). Cancer. 1999;86:364\u201372.","journal-title":"Cancer"},{"key":"580_CR11","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/S0022-3468(79)80003-2","volume":"14","author":"HL Zheng","year":"1979","unstructured":"Zheng HL, Maruyama T, Matsuda S, Satomura K. Neuroblastoma presenting with the nephrotic syndrome. J Pediatr Surg. 1979;14:414\u20139.","journal-title":"J Pediatr Surg"},{"key":"580_CR12","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1159\/000331211","volume":"4","author":"GM Poggi","year":"2011","unstructured":"Poggi GM, Fognani G, Cuzzubbo D, Liguori A, Resti M, Pela I. Neuroblastoma presenting with acute kidney injury, hyponatremic-hypertensive-like syndrome and nephrotic proteinuria in a 10-month-old child. Case Rep Oncol. 2011;4:400\u20135.","journal-title":"Case Rep Oncol"},{"key":"580_CR13","doi-asserted-by":"publisher","first-page":"184","DOI":"10.5414\/CN108593","volume":"85","author":"F Inayat","year":"2016","unstructured":"Inayat F, Law JK, Myers-Gurevitch PM, et al. Minimal change disease: an unusual presentation of marginal zone MALT lymphoma. Clin Nephrol. 2016;85:184\u20138.","journal-title":"Clin Nephrol"},{"key":"580_CR14","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/S0272-6386(12)70160-9","volume":"22","author":"DM Burstein","year":"1993","unstructured":"Burstein DM, Korbet SM, Schwartz MM. Membranous glomerulonephritis and malignancy. Am J Kidney Dis. 1993;22:5\u201310.","journal-title":"Am J Kidney Dis"},{"key":"580_CR15","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/S0140-6736(74)91880-7","volume":"2","author":"RJ Shalhoub","year":"1974","unstructured":"Shalhoub RJ. Pathogenesis of lipoid nephrosis: a disorder of T-cell function. Lancet. 1974;2:556\u201360.","journal-title":"Lancet"},{"key":"580_CR16","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1038\/sj.ki.5000341","volume":"69","author":"V Audard","year":"2006","unstructured":"Audard V, Larousserie F, Grimbert P, Abtahi M, Sotto JJ, Delmer A, Boue F, Nochy D, Brousse N, Delarue R, Remy P, Ronco P, Sahali D, Lang P, Hermine O. Minimal change nephrotic syndrome and classical Hodgkin\u2019s lymphoma: report of 21 cases and review of the literature. Kidney Int. 2006;69:2251\u201360.","journal-title":"Kidney Int"},{"key":"580_CR17","doi-asserted-by":"publisher","first-page":"3756","DOI":"10.1182\/blood-2009-11-251132","volume":"115","author":"V Audard","year":"2010","unstructured":"Audard V, Zhang SY, Copie-Bergman C, Rucker-Martin C, Ory V, Candelier M, Baia M, Lang P, Pawlak A, Sahali D. Occurrence of minimal change nephrotic syndrome in classical Hodgkin lym- phoma is closely related to the induction of c-mip in Hodgkin-Reed Sternberg cells and podocytes. Blood. 2010;115:3756\u201362.","journal-title":"Blood"},{"key":"580_CR18","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1093\/ndt\/18.2.245","volume":"18","author":"P Grimbert","year":"2003","unstructured":"Grimbert P, Audard V, Remy P, et al. Recent approaches to the pathogenesis of minimal-change nephrotic syndrome. Nephrol Dial Transplant. 2003;18:245\u20138.","journal-title":"Nephrol Dial Transplant"},{"key":"580_CR19","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/S0065-230X(02)84009-X","volume":"84","author":"R Kuppers","year":"2002","unstructured":"Kuppers R. Molecular biology of Hodgkin\u2019s lymphoma. Adv Cancer Res. 2002;84:277\u2013312.","journal-title":"Adv Cancer Res"},{"key":"580_CR20","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.3389\/fimmu.2017.01473","volume":"3","author":"P Zhang","year":"2017","unstructured":"Zhang P, Wu X, Basu M, Dong C, Zheng P, Liu Y, Sandler AD. MYCN Amplification is associated with repressed cellular immunity in neuroblastoma: an in silico immunological analysis of TARGET database. Front Immunol. 2017;3:1473.","journal-title":"Front Immunol"},{"key":"580_CR21","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2017.1320626","author":"JP Layer","year":"2017","unstructured":"Layer JP, Kronm\u00fcller MT, Quast T, van den Boorn-Konijnenberg D, Effern M, Hinze D, Althoff K, Schramm A, Westermann F, Peifer M, Hartmann G, T\u00fcting T, Kolanus W, Fischer M, Schulte J, H\u00f6lzel M. Amplification of N-Myc is associated with a T-cell-poor microenvironment in metastatic neuroblastoma restraining interferon pathway activity and chemokine expression. Oncoimmunology. 2017. https:\/\/doi.org\/10.1080\/2162402X.2017.1320626.","journal-title":"Oncoimmunology"},{"key":"580_CR22","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1159\/000187585","volume":"65","author":"C Sungur","year":"1993","unstructured":"Sungur C, Ozyilkan E, Akpolat T, Yasavul U, Turgan C, Caglar S. Relapse of minimal change disease associated with alpha-interferon therapy. Nephron. 1993;65:648.","journal-title":"Nephron"},{"key":"580_CR23","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1002\/pbc.20859","volume":"49","author":"N Esiashvili","year":"2007","unstructured":"Esiashvili N, Goodman M, Ward K, Marcus RB Jr, Johnstone PA. Neuroblastoma in adults: incidence and survival analysis based on SEER data. Pediatr Blood Cancer. 2007;49:41\u20136.","journal-title":"Pediatr Blood Cancer"},{"key":"580_CR24","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/2162-3619-3-20","volume":"3","author":"E Rogowitz","year":"2014","unstructured":"Rogowitz E, Babiker HM, Kanaan M, Millius RA, Ringenberg QS, Bishop M. Neuroblastoma of the elderly, an oncologist\u2019s nightmare: case presentation, literature review and SEER database analysis. Exp Hematol Oncol. 2014;3:20.","journal-title":"Exp Hematol Oncol"},{"key":"580_CR25","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1126\/science.8122112","volume":"263","author":"SW Morris","year":"1994","unstructured":"Morris SW, Kirstein MN, Valentine MB, Dittmer KG, Shapiro DN, Saltman DL, Look AT. Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin\u2019s lymphoma. Science. 1994;263:1281\u20134.","journal-title":"Science"},{"key":"580_CR26","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/S0002-9440(10)64550-6","volume":"157","author":"B Lawrence","year":"2000","unstructured":"Lawrence B, Perez-Atayde A, Hibbard MK, Rubin BP, Dal Cin P, Pinkus JL, Pinkus GS, Xiao S, Yi ES, Fletcher CD, Fletcher JA. TPM3-ALK and TPM4-ALK oncogenes in inflammatory myofibroblastic tumors. Am J Pathol. 2000;157:377\u201384.","journal-title":"Am J Pathol"},{"key":"580_CR27","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/nature05945","volume":"448","author":"M Soda","year":"2007","unstructured":"Soda M, Choi YL, Enomoto M, Takada S, Yamashita Y, Ishikawa S, Fujiwara S, Watanabe H, Kurashina K, Hatanaka H, et al. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. Nature. 2007;448:561\u20136.","journal-title":"Nature"},{"key":"580_CR28","doi-asserted-by":"publisher","first-page":"3312","DOI":"10.1158\/0008-5472.CAN-11-3931","volume":"72","author":"H Ren","year":"2012","unstructured":"Ren H, Tan ZP, Zhu X, Crosby K, Haack H, Ren JM, Beausoleil S, Moritz A, Innocenti G, Rush J, et al. Identification of anaplastic lymphoma kinase as a potential therapeutic target in ovarian cancer. Cancer Res. 2012;72:3312\u201323.","journal-title":"Cancer Res"},{"key":"580_CR29","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.ccell.2014.09.019","volume":"26","author":"SC Bresler","year":"2014","unstructured":"Bresler SC, Weiser DA, Huwe PJ, Park JH, Krytska K, Ryles H, Laudenslager M, Rappaport EF, Wood AC, McGrady PW, Hogarty MD, London WB, Radhakrishnan R, et al. ALK mutations confer differential oncogenic activation and sensitivity to ALK inhibition therapy in neuroblastoma. Cancer Cell. 2014;26:682\u201394.","journal-title":"Cancer Cell"},{"key":"580_CR30","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/nature10910","volume":"483","author":"JJ Molenaar","year":"2012","unstructured":"Molenaar JJ, Koster J, Zwijnenburg DA, van Sluis P, Valentijn LJ, van der Ploeg I, Hamdi M, van Nes J, Westerman BA, van Arkel J, Ebus ME, Haneveld F, Lakeman A, et al. Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes. Nature. 2012;483:589\u201393.","journal-title":"Nature"},{"key":"580_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1006501","author":"OM Padovan-Merhar","year":"2016","unstructured":"Padovan-Merhar OM, Raman P, Ostrovnaya I, Kalletla K, Rubnitz KR, Sanford EM, Ali SM, Miller VA, Mosse YP, Granger MP, Weiss B, Maris JM, Modak S. Enrichment of targetable mutations in the relapsed neuroblastoma genome. PLoS Genet. 2016. https:\/\/doi.org\/10.1371\/journal.pgen.1006501.","journal-title":"PLoS Genet"},{"key":"580_CR32","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1510\/icvts.2010.262204","volume":"13","author":"Y Ohtaki","year":"2011","unstructured":"Ohtaki Y, Ishii G, Hasegawa T, Nagai K. Adult neuroblastoma arising in the superior mediastinum. Interact Cardiovasc Thorac Surg. 2011;13:220\u20132.","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"580_CR33","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1002\/gcc.22826","volume":"59","author":"K Duan","year":"2020","unstructured":"Duan K, Dickson BC, Marrano P, Thorner PS, Chung CT. Adult-onset neuroblastoma: report of seven cases with molecular genetic characterization. Genes Chromosomes Cancer. 2020;59:240\u20138.","journal-title":"Genes Chromosomes Cancer"}],"container-title":["CEN Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-021-00580-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13730-021-00580-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-021-00580-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,9]],"date-time":"2021-07-09T07:17:41Z","timestamp":1625815061000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13730-021-00580-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,17]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["580"],"URL":"https:\/\/doi.org\/10.1007\/s13730-021-00580-3","relation":{},"ISSN":["2192-4449"],"issn-type":[{"type":"electronic","value":"2192-4449"}],"subject":[],"published":{"date-parts":[[2021,2,17]]},"assertion":[{"value":"8 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All the authors have declared no competing interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All of the treatment and the examination followed the guideline laid down in the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statement"}},{"value":"Informed consent was obtained from the patient\u2019s family in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}